Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Imaging Brain Chemistry and Function in Neuropsychiatric Disorders
Peter C Williamson
PDF

In Review
In vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders
Jeffrey A Stanley
PDF

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging
Cheryl L Grady, Michelle L Keightley

PDF

Review Papers
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies

Russell Schachar, Alejandro R Jadad, Mary Gauld, Michael Boyle, Lynda Booker, Anne Snider, Marie Kim, Charles Cunningham

PDF

Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder
Kieran D O'Malley, Jo Nanson

PDF

Original Research
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment

Dennis Wardman, Nadia Khan, Nady el-Guebaly

PDF

The Impact of Latitude on the Prevalence of Seasonal Depression
Anthony J Levitt, Michael H Boyle

PDF

Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders
OJ Oluboka, SL Stewart, V Sharma, D Mazmanian, E Persad

PDF

Brief Communciation
Hepatic Adverse Reactions Associated With Nefazodone
Donna E Stewart

PDF


Book Reviews
(PDF - all reviews)

Functional Neuroimaging in Child Psychiatry

Handbook of Cultural Psychiatry

The Empathetic Healer: An Endangered Species?

Cognitive Rehabilitiation: An Integrative Neuropsychological Approach

The Madness of Adam and Eve: How Schizophrenia Shaped Humanity


Letters to the Editor
(PDF - all letters)

Evidence-Based Psychiatry

Evidence-Based Psychiatry: Response

Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others

Research Ethics and Forensic Psychiatry: Response

Repetitive Transcranial Magnetic Stimulation is Useful for Maintenance Treatment

The Mood Disorder Questionnaire for Assessing Bipolar Spectrum Disorder Frequency

Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis

Re: New Centry: Overcoming Stigma, Respecting Differences—Dr Myers' Superlative Presidential Address

Steroid-Induced Psychosis Treated With Risperidone

In Review

In Vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders

Jeffrey A Stanley, PhD1

 

In vivo magnetic resonance spectroscopy (MRS) is the only noninvasive imaging technique that can directly assess the living biochemistry in localized brain regions. In the past decade, spectroscopy studies have shown biochemical alterations in various neuropsychiatric disorders. These first-generation studies have, in most cases, been exploratory but have provided insightful biochemical information that has furthered our understanding of different brain disorders. This review provides a brief description of spectroscopy, followed by a literature review of key spectroscopy findings in schizophrenia, affective disorders, and autism.

In schizophrenia, phosphorus spectroscopy studies have shown altered metabolism of membrane phospholipids (MPL) during the early course of the illness, which is consistent with a neurodevelopmental abnormality around the critical period of adolescence when the illness typically begins. Children and adolescents who are at increased genetic risk for schizophrenia show similar MPL alterations, suggesting that schizophrenia subjects with a genetic predisposition may have a premorbid neurodevelopmental abnormality.

Independent of medication status, bipolar subjects in the depressive state tended to have higher MPL precursor levels and a deficit of high-energy phosphate metabolites, which also is consistent with major depression, though these results varied. Further bipolar studies are needed to investigate alterations at the early stage.

Lastly, associations between prefrontal metabolism of high-energy phosphate and MPL and neuropsychological performance and reduced N-acetylaspartate in the temporal and cerebellum regions have been reported in individuals with autism. These findings are consistent with developmental alterations in the temporal lobe and in the cerebellum of persons with autism. This paper discusses recent findings of new functions of N-acetylaspartate.

(Can J Psychiatry 2002;47:315–326)

Key Words: in vivo, proton, phosphorus, spectroscopy, schizophrenia, bipolar, depression, autism

Résumé : La spectroscopie par résonance magnétique in vivo et son application aux troubles neuropsychiatriques


Our understanding of biochemical and molecular underpinnings leading to neuropsychiatric disorders is continually growing, owing in part to contributions from in vivo magnetic resonance spectroscopy (MRS) to the psychiatric field. In vivo spectroscopy is the only noninvasive technique that can directly assess the living biochemistry in localized brain regions (1). In addition, recent advancements in magnetic resonance (MR) hardware and software technologies have greatly improved the quality of spectroscopy data, especially the spatial and biochemical resolution, and the accuracy and precision of quantifying the biochemistry. The success of in vivo spectroscopy over the past decade has led to useful findings concerning the pathophysiology of different neuropsychiatric disorders. The purpose of this review is first to provide a brief description of spectroscopy and what it can do, followed by a literature review of key findings of in vivo spectroscopy studies in schizophrenia, affective disorders, and autism. It will conclude with a discussion of possible future directions for in vivo spectroscopy in neuropsychiatric disorders.

Click here for a list of abbreviations and acronyms used in this paper.

 

What is Magnetic Resonance Spectroscopy?

Both MRS and magnetic resonance imaging (MRI) technologies are governed by the principles of nuclear magnetic resonance (NMR). While the more popular MRI technique provides cross-sectional anatomic images based on the tissue water content, MRS is a technique that can measure the in vivo biochemical or metabolite concentration levels in the human body from a specific localized region. As implied in the name, MRS requires a magnetic field and a radio-frequency (RF) transmit pulse that is at a particular resonant frequency to observe the signal of specific nuclei (for example, proton [1H] or phosphorus [31P]) in the sample of interest. The end product of MRS is a “spectrum” with a frequency axis in parts per million (ppm) and a signal amplitude axis. Specific nuclei contained in a metabolite give rise to either a single peak or multiple peaks that are uniquely positioned along the frequency axis, and the peak position is known as the chemical shift; the signal amplitude of a peak, which is quantified, is directly related to the concentration of that assigned metabolite. Details on the MR basic principles and applications are described elsewhere (2–4).